These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2642457)
1. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma. Smith JL; Jones DB; Bell AJ; Wright DH Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650 [TBL] [Abstract][Full Text] [Related]
5. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211 [TBL] [Abstract][Full Text] [Related]
6. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. Salter DM; Krajewski AS; Cunningham S J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770 [TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of non-Hodgkin's lymphomas: correlation of morphological appearances and immunophenotype in 148 cases. Nash JR Histopathology; 1986 Aug; 10(8):793-813. PubMed ID: 3489661 [TBL] [Abstract][Full Text] [Related]
8. Correlation of immunophenotype to morphology in unfavourable non-Hodgkin lymphoma. Christensson B; Lindemalm C; Johansson B; Mellstedt H; Ost A; Biberfeld P Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):425-33. PubMed ID: 6364691 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic heterogeneity displayed by T-non Hodgkin's lymphoma (T-NHL) cells dispersed from diagnostic lymph node biopsies. Jones DB; Wright DH; Paul F; Smith JL Hematol Oncol; 1986; 4(3):219-26. PubMed ID: 3490424 [TBL] [Abstract][Full Text] [Related]
10. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD). Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Ebrahim SA; Ladanyi M; Desai SB; Offit K; Jhanwar SC; Filippa DA; Lieberman PH; Chaganti RS Genes Chromosomes Cancer; 1990 May; 2(1):27-35. PubMed ID: 2177640 [TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival. Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475 [TBL] [Abstract][Full Text] [Related]
14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas. Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567 [TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies. Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849 [TBL] [Abstract][Full Text] [Related]
18. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822 [TBL] [Abstract][Full Text] [Related]
19. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance]. Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418 [TBL] [Abstract][Full Text] [Related]
20. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications. Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]